Posterior Capsule Opacification and Glistenings of New Single-Piece Hydrophobic Acrylic IOL: 12-Month Evaluation

Monday, April 28, 2014: 3:59 PM
Room 155 (Boston Convention and Exhibition Center)
Zeki Tunc, MD, Maltepe Univercity, ISTANBUL, Turkey
Firat Helvacioglu, MD, Maltepe University, Istanbul, Turkey
Sadik Sencan, MD, Maltepe University, Istanbul, Turkey

Narrative Responses:

Purpose
To evaluate and assess the presence of glistening and posterior capsule opacification (PCO) rates at 12 months for the new E-1 hydrophobic acrylic single-piece IOL in 45 eyes.

Methods
Using a routine eye exam, 45 eyes were examined at 12 months.  Follow-up evaluations included slit-lamp examination, assessment of transparency (absence of vacuoles) and PCO, and patient satisfaction. Retro illuminated images were analyzed for the presence of PCO. Severity of the capsule opacification was graded as none, mild, moderate and severe. The percentage of the area of PCO was also evaluated.

Results
The 12 month results will be reported on 45 eyes. PCO was not observed in most of the patients, only peripheral mild opacification was observed in a few patients. Mean percentage of PCO area was 1.48 % and mean severity grade of PCO was 0,014. The E-1 is well-centered and remains transparent through the 12 month follow-up visits with no appearance of vacuoles or glistenings. Capsules have also remained clear with no Nd:YAG capsulotomies required.

Conclusion
The E-1 is a new hydrophobic acrylic IOL. 45 subjects followed to 12 months required no Nd:YAG procedures and no appearances of glistenings.